Richard Mishaan is a well known personality in the interior design industry. Richard Mishaan design creates comfortable and luxury homes for families. His field involves hotels, homes and indoor design. Many people acknowledge him as an incredible architect and a transformative designer through his lighting and furniture line. Richard Mishaan design can convert a 17th-century console into a beautiful juxtaposition.
Mr. Mishaan has worked at Karen Silverman’s home, a grand hotel in Columbia and for various residences in New York, the Dominica Republic, and Florida. Richard Mishaan design is mainly experienced at his furniture shop in Greenwich Village that sells different products from contemporary or vintage. In the store, Richard stocks furniture transforming them four times a year. The transformation lightens up the furniture. His furniture is of high quality, and in his own home, he owns a couch of 20 years old.
Richard Mishaan Design primarily surrounds transforming a small space to a magical and attractive result. Richard usually opens a space then paints the ceilings and walls with a warm white color. His design includes buying comfortable low club chairs to open up the living room and also he encourages floating beds for space. His previous home was full of his design with a museum art, beautiful furniture, sculpture in a park, vaulted ceiling and an original wooden board among others. Richard Mishaan design embraces the clients’ demands and preferences and not his.
Mishaan is a native of Columbia. Richard studied at the Columbia University School of Architecture paving his way to New York University studying BA. His career journey began as an apprentice at Philip Johnson offices. With his passion for art and design, Mishaan grew his skills tremendously extending to working for high-end residential and commercial buildings. Many people have appreciated Richard Mishaan design. With his unique taste in interior design, Richard has been leading in the industry for his stylish designs.
Whitney Wolfe may be the founder and CEO of a successful company but she’s actually just like the rest of us. Wolfe knows what it’s like to dive into the awkwardness that online dating and dating in general. She looked at the whole idea and how things operate and realized that there was something very broken about the system. Wolfe worked for popular dating app Tinder and she saw a lot of flaws in the company and how dating worked. She realized that men dominated and they didn’t always treat women the greatest. She also realized it wasn’t the safest place.
Therefore, Wolfe broke away after a lawsuit of sexual harassment. She decided that she needed to do something for women everywhere. That’s how Whitney Wolfe came to create popular online dating app Bumble. Today, there are millions of users. That’s because Wolfe created an app that so many of us can relate to. She created an app where women call the shots, make the moves, and ultimately travel along at their own pace. There’s no pressure, the app is a lot safer, and women are loving the fact that they get to make decisions! In what seems male-dominated society, this is a way that women have some power.
It’s easy to see what her app is drawing attention from the other apps. They realized that there is a market for a place where women can make the decisions and they’re possibly getting a little bit jealous and nervous. According to Forbes, that’s why Whitney Wolfe was just offered a $450 million deal to sell Bumble to Match Group. She declined and women everywhere are thankful. They’re loving this safe space that Wolfe created and they don’t want to see it turn into another app that’s similar to Tinder or Match.
Bumble and Whitney Wolfe are helping women everywhere find their voices. Wolfe is a firm believer in feminism, equality, and just being kind to one another. At the end of the day, everyone wins as long as Wolfe remains in charge of Bumble. Women get to continue calling the shots.
Three years ago Everolimus was only an idea. When this drug, similar to rapamycin showed improvement in human immunity, it was time to celebrate. It was a step closer to people trying to slow down ageing. It was believed for a long time that ageing happens because on a molecular level, the body cannot repair itself quite as good as the time goes on.However, rapamycin and drugs similar to it can be used to effectively improve people’s condition, prevent diseases and slow down the possible damage done to the cells. Mikhail Blagosklonny is one of the scientists working on using rapamycin and other similar drugs to slow down ageing and treat cancer. At the moment research shows that rapamycin can be administered to people with osteoporosis and improve the life expectancy with people with Alzheimer’s. It is a drug currently administered to transplant receivers so that their bodies wouldn’t reject the newly transplanted organ. There is not enough research at the moment to know for sure what other properties Rapamycin will unravel, but it isn’t toxic, and people have not reported allergic reactions to it.
Mikhail Blagosklonny worked as a professor of oncology at the Roswell Park Cancer Institute before his interest in the connection between cancer and research started. He has both an M.D. and PhD. Experimental medicine and cardiology were his fields of study at the First Pavlov State Medical University of St. Petersburg.His career started in New York where he worked as an associate professor of medicine. Afterwards, his career led him from Valhalla to Albany where Blagosklonny applied his knowledge and expertise as scientists at the Ordway Research Institute.He worked there till 2009 when Roswell Park invited him to come onboard. His research mainly concentrates on cancer and mechanisms of ageing as well as preventative medicine.He believes that helping people to avoid cancer from appearing might be the way forward.
Any treatment that could be administered before the cancerous cells appear and multiply would allow people to not get sick in the first place. It would not right out cure patients with advanced forms of cancer, but it would decrease risks for others. It’s possible that it would eventually lead scientists to a complete cure of this debilitating disease.Mikhail Blagosklonny also works in publishing. He’s the editor of several peer-review publications, such as Cell Cycle and Oncotarget. He gives young scientist opportunities to be published and get reviewed by esteemed professionals in the field as well as their peers.Oncotarget keeps people informed about the newest discoveries and research I the field of oncology. Since Mikhail Blagosklonny is interested in the subject of cancer himself, he enjoys working with young professionals and scientists discovering new facts about cancer and its various forms.His passion and dedication are noted by his peers, and his colleagues enjoy his company and his knowledge. Mikhail Blagosklonny has a personal approach to every new research project he takes on since people’s lives could be dramatically changed because of it.
Two prolific journalists in the media industry were arrested by the Maricopa police due to claims that were later settled. Michael Lacey and Jim Larkin were shocked in the middle of the night to be handcuffed by Joe Arpaio at their respective homes and driven to the police station without a clue of what was exactly happening. On their arrest, Joe Arpaio, the city sheriff accused them of breaking the law because they published news about him that was not so pleasing to read. Lacey and Larkin, the two principal executives of the Village Voice media, were displeased by the Sherrif`s claims and requested to deal with him in the court of law.
Arpaio always termed himself as one of the most feared sheriffs in the state of Arizona and most cases he was always terrible to his victims. The feared sheriff in town took another significant step to look for any individual that read the published issue that had exclusively featured him. He threatened to arrest the readers of the magazine and prosecute them in the court of law, just like he had done to Michael and Lacey. Due to the disturbing stories in the social platforms concerning the arrest of the two prolific journalist, a lot of concerns was raised by their readers and fans who wanted to know why they were arrested and also demanded investigations be conducted based on the Joe Arpaio`s claims, which they termed as wicked. The fans of the two journalists saw the claims as not valid and worth their arrest.
Arpaio accused the two journalists of acting against the law and challenging his leadership unlawfully. Michael and Lacey had published on the sheriff’s prisons sorry state and went ahead to explain his harsh treatment to the inmates. Besides, they accused him of not treating his employees well and abusing his power.
Due to the people’s pressure on the release of the two executives, the sheriff got them out of their separate cells and let them go home. Michael and Lacey then filed a petition in court to challenge the annoying arrest by the sheriff. The jury involved in listening to the case noted that the detention of the two was more of an assault which was against the law. The jury found Arpaio guilty of his deeds, and the two were highly compensated with a huge amount of money. Michael and Lacey then used the cash to start up the Frontera Fund through which they began to address various issues like human rights, immigration rights, freedom of speech, among others.
Desiree Perez; One of the Brightest Women Dominating the Entertainment Industry
When the name Jay-Z is mentioned, Desiree Perez inevitably pops up. For those who are not familiar with the name, Des Perez is the woman that is partly behind the success of Jay-Z. She has been with him for a little over 23 years and during this time, Jay-Z has grown from being just an artist to a reputable artist and a wealthy businessman. In short, that is what Desiree Perez does, transform peoples’ lives.
Des Perez is the one who helped to stabilize Tidal. Tidal had for a long time been having management issues, but since Jay-Z called Des to be part of the team, things have not been the same. Tidal is today competing with music streaming platforms such as iTunes and Spotify. All this is courtesy of strategic decision making done by Desiree Perez. Within the few years that she has been with Tidal, she has enabled it to be a multi-million business with millions of subscribers and millions subscribing on a monthly basis. Related article on runninglip.com
Aside from being on the management team of Tidal, Des Perez is integral in the running and success of Rock Nation. Hers is to help in getting clients better contracts terms that will increase their net worth and help them in bettering themselves. She manages the likes of Meek Mill, Rihanna and Beyoncé. She ensures that contracts do not disadvantage them. Also, she is in charge of their reputation. Head over to prettymanprettyman.com to read more about Dez.
So far, as an executive of Rock Nation, she has successfully planned Beyoncé’s world tour, which was a big hit and brought a lot of money, both to Beyoncé and the company. She also boasts of having helped Rihanna to get a huge contract with Samsung. She does all these and yet continues to be behind the scenes. Check hitsdailydouble.com.
InnovaCare Health, based in Fort Lee New Jersey, is a healthcare management company offering Medicare and Medicaid Advantage plans. They are the leading provider of managed health care services in North America. InnovaCare Health is striving to build managed health care models that are coordinated, cost-effective, innovative, and driven by quality. They do this by putting patients first and developing strong patient-provider relationships. Their models are innovative and focus on quality health care solutions. Top-quality leadership is essential to make this happen. InnovaCare has the outstanding leadership of Dr. Richard Shinto and Penelope Kokkinides.
Dr. Richard Shinto is President and CEO of InnovaCare with more than 20 years of clinical and operational health care experience. Before assuming this role in 2008, Dr. Shinto was COO and Chief Medical Officer at Medical Pathways Management Company. He has also held top management positions at Medical Management for MedPartners, Cal Optima Health Plan, and NAMM California. Shinto earned his Bachelors in Science from University of California and his medical degree from State University of New York. In addition, Dr. Shinto has an M.B.A. from University of Redlands. In 2012, He won Ernst& Young’s Entrepreneur of the Year Award.
In July 2016, Dr. Shinto announced the new Chief Administrative Officer of InnovaCare Penelope Kokkinides. Before being promoted she was COO and Vice President of Clinical Operations at InnovaCare. Kokkinides has over 20 years of healthcare experience, and she specializes in simplifying the process of working with governmental agencies. She too has served in top management positions at Centerlight HealthCare, Touchstone Health, and AmeriChoice. Kokkinides earned her bachelor’s degree in biological sciences and classical languages from Binghamton University. She has a Master’s degree in social work from New York University and a Master’s degree in public health from Columbia University School of Public Health. Kokkinides obtained a post master’s program advanced degree in alcohol and substance abuse as well.
Under the leadership of Dr. Richard Shinto and Penelope Kokkinides, InnovaCare works to ensure all stakeholders are pleased with the healthcare process. InnovaCare strives to see patients receive top-quality affordable care while building sustainable, innovative, and cost effective networks for healthcare providers. InnovaCare’s two Medicare Advantage plans in Puerto Rico earned four-star ratings from the government demonstrating excellence in patient experience and access. Besides Medicare Advantage plans, InnovaCare also offers Vita Care which focuses on chronic conditions and Caribbean Accountable Care which is a shared savings program.
Fabletics was founded in 2013 as the athleisure brand that is also fashionable. This design company wanted to make their clothes to be empowering for women. Since then, the team of people who work at Fabletics have turned it into a $250 million dollar brand. Kate Hudson is the main reason this brand has took off as well as it has. This isn’t bad for someone who came into with absolutely no business background.
The TechStyle Fashion Group founders Adam Goldenberg and Don Ressler shared the idea of creating a athletic brand which was stylish since there wasn’t any already out there. At the time, most of your athletic wear was black or grey and were simply over-priced. In order for them to be able to do this, they needed someone to come in as a partner. The very first person who came to mind was Kate Hudson. They knew that as her as their partner, they had everything they wanted for their company. Kate is someone that is approachable, who doesn’t take life so serious and who is active herself in working out.
From the very beginning, Kate made sure she was involved in all the steps of creating Fabletics. It didn’t matter if it was simply going over budgets, deciding on a social media post or anything else that the company needed and wanted done. She was very active in ensuring that the styles would always remain as fresh. Each week that the team collects sales data, Kate goes over the numbers to make sure that the sales are going the way that they should.
By taking the Lifestyle Quiz, the data which is collected through the quiz is what helps the member find the outfit that is perfect for them. The data will remember what the personalized information was and the choices the person liked and will compute a specific type of gear that the person should use. It’s almost like having your own personal shopper doing the work for you.
When it comes to celebrities endorsing what they sell, most of the celebrities that you see endorsing something don’t actually use the product themselves. There are some examples of this like Cindy Crawford who uses her beauty routine products but for the most part, most people don’t. Kate Hudson however is someone who knows the brand, trusts it and uses it herself. She doesn’t just sell the stuff, she uses it herself when she works out in her own gym.
The quest to find a cure for treating cancer has been a war that has been waging on for decades now with many scientists all over the world dedicating their time and their entire lives to it. This has seen many governments and private entities invest so much in the establishments of cancer research centers with the sole purpose of deep study and finding of a cure. One good example of such a facility is the Seattle Genetics that was established by Dr. Clay Siegall. Dr. Clay founded Seattle Genetics in the year 1998.
The research company has over two decades now grown to become one of the leading research businesses and with the help of Dr. Siegall went on to develop one of its First antibody drug conjugate that was approved by FDA for use by the public. To add to this great achievement was followed by the research company developing more than twenty other drugs that were approved for the treatment of many other diseases. The research company has over the years been developing many other new lines of drugs to help continue the fight against diseases.
Dr. Clay Siegall is a very remarkable scientist whose initial interest in research and medicine began while he was still a very young boy. His interest was specifically to the field of medicine and always found the aspect of combining technology and medicine to be a topic that had so much potential if applied together to help fight diseases. This motivated him to follow up a career in science when he joined the University of Maryland and studied Zoology.
It was while pursuing her undergraduate studies in Zoology, that Dr. Siegall interest in medicine was re-ignited when one of his close family members was diagnosed with cancer. The treatment regiments that were used to treat the family member shocked Dr. Clay since they were brutal and almost led to the family member to lose their life. This prompted him to turn around his life and dedicate his life to try and find new treatment methods to be used in the treatment of those who have cancer. He sought to improve and make the regiment treatments less painful when administered to cancer patients and to his credit he was able to achieve this and has immensely contributed to the war on cancer.
Paul Mampilly left Wall Street after the 2008 crash that people suffered while hedge fund managers still collected their pay. He has 20 years of experience, and he left Wall Street to help ordinary investors who had made huge losses during the crash to get profitable stocks. With this experience, he started his firm Capuchin Consulting in Durham.
At the beginning of the crash, he managed a private account and won an award for achieving record returns. He took a risk that paid off in 76% gains while most feared a financial collapse. He found out that the reason most investors fail is that they buy stocks at the wrong time in the market.
As the Investment Director and Editor of FDA trader, he came up with ideas for Agro Financial and as the founder of his firm he helped many ordinary Americans make plenty of wealth.
Tory recently joined Banyan Hill Publishing and had a platform for Profits Unlimited, a newsletter dealing with investments with over 60,000 subscribers that get updated every week on the performance of the stocks in the market.
Paul Mampilly has a video that shows his viewers successful stocks he has selected and displays stock performance with stock values having dramatic trajectories. He has a college degree, but most of his profession is credited by the trial and error method. A degree is a stepping stone to getting a job but reading a lot of books was the basis of his success.
Tory explained to the investment head at Banyan Hill that he thinks a trend that will have a lot of profits is focusing on the millennial generation. Another trend he sees is the development of the Internet of Things where devices can be synced to each other and performing various tasks.
Principles are very important to Mr. Mampilly, and this was the reason he left Wall Street, to help others. He chooses to use his experience in managing a hedge fund to help his clients who respect and appreciate it.
About Paul Mampilly
Paul Mampilly is currently the senior editor at Banyan Hill Publishing where he specializes in helping the ordinary American grow wealth by investing in various sectors of technology and the stock exchange market.
Oncotarget, a weekly peer-reviewed journal first opened its virtual doors in 2010; it’s first articles were released in may of that same year. While Oncotarget has an extensive and experience board of editors, it is overseen by the two primary editors-in-chief: Mikhail Blagosklonny and Andrei Gudkov. Blagosklonny himself has published over 270 papers in various peer-reviewed journal on dovepress.com (including Oncotarget and others), giving the site quite a background with his experience alone.
At the time of this writing, Oncotarget has over 150 single issues in its back catalog, with the majority of those issues containing dozens of articles from subjects ranging from DNA sequencing to better understand cancer to the efficiency of various drugs in direct cancer treatment, giving the side a wide breadth of oncology information. To access Oncotarget’s archives you can go to their website and browse to the “Archive” section on the left sidebar, or see the current issue under the same name. In the archive section on impactjournals.com you can browse the complete history of Oncotarget’s library of articles in chronological, descending order.
In addition to their powerful site, Oncotarget has a presence on most of the popular social media platforms including Facebook, Twitter, Youtube, Google Plus and LinkedIn. To access the current listing of all presences on various platform, the easiest method is to go to their homepage and click the icons for the various platforms in the upper right-hand corner. The youtube page especially is a wonderful resource; at this time it covers over 15 interviews with various Oncology experts that go into further detail about their featured papers on Oncotarget. The rest of the social media platforms provide an excellent place to receiving continuing updates about popular articles and interaction with the rest of the cancer research community on bioxbio.com.